Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1992
Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer
J Pedersen-Bjergaard, T C Sigsgaard, D Nielsen, et al.
The New England Journal of Medicine
|
April 21, 1988
Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma
J Pedersen-Bjergaard, J Ersbøll, V L Hansen, et al.
Leukemia
|
June 1, 1991
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark
O P Hansen, J Pedersen-Bjergaard, J Ellegaard, et al.
Leukemia
|
December 1, 1993
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series
J Pedersen-Bjergaard, P Philip, S O Larsen, et al.
Leukemia
|
January 1, 1997
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML
P de Nully Brown, T Hoffmann, O P Hansen, et al.
Blood
|
December 15, 1993
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II
H J Super, N R McCabe, M J Thirman, et al.
European Journal of Haematology
|
September 30, 1998
BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem-cell source and previous treatment
C H Geisler, M M Hansen, N S Andersen, et al.
Scandinavian Journal of Haematology
|
July 1, 1980
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA
N I Nissen, A M Nordentoft, H Brincker, et al.
Cancer Research
|
March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11
M A Caligiuri, M P Strout, S A Schichman, et al.
Cancer
|
January 1, 1979
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B
N I Nissen, T F Pajak, O Glidewell, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1992
Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer
J Pedersen-Bjergaard, T C Sigsgaard, D Nielsen, et al.
The New England Journal of Medicine
|
April 21, 1988
Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma
J Pedersen-Bjergaard, J Ersbøll, V L Hansen, et al.
Leukemia
|
June 1, 1991
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark
O P Hansen, J Pedersen-Bjergaard, J Ellegaard, et al.
Leukemia
|
December 1, 1993
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series
J Pedersen-Bjergaard, P Philip, S O Larsen, et al.
Leukemia
|
January 1, 1997
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML
P de Nully Brown, T Hoffmann, O P Hansen, et al.
Blood
|
December 15, 1993
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II
H J Super, N R McCabe, M J Thirman, et al.
European Journal of Haematology
|
September 30, 1998
BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem-cell source and previous treatment
C H Geisler, M M Hansen, N S Andersen, et al.
Scandinavian Journal of Haematology
|
July 1, 1980
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA
N I Nissen, A M Nordentoft, H Brincker, et al.
Cancer Research
|
March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11
M A Caligiuri, M P Strout, S A Schichman, et al.
Cancer
|
January 1, 1979
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B
N I Nissen, T F Pajak, O Glidewell, et al.
Page
of 10